Na Xu

Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss

Johann S. de Bono, Ugo De Giorgi, Daniel Nava Rodrigues et al. · Clinical Cancer Research · 2018 · 310 citations

Medicine, Oncology, Pharmacology +15

Nanoscale Melittin@Zeolitic Imidazolate Frameworks for Enhanced Anticancer Activity and Mechanism Analysis

Yawei Li, Na Xu, Wenhe Zhu et al. · ACS Applied Materials & Interfaces · 2018 · 77 citations

Pharmacy, Oncology, Pharmacology +16

Comparison of senescence-related changes between three- and two-dimensional cultured adipose-derived mesenchymal stem cells

Qiliang Yin, Na Xu, Dongsheng Xu et al. · Stem Cell Research & Therapy · 2020 · 73 citations · Full text

Life Sciences, Bioengineering, Cell Biology +17

Facile synthesis of a metal–organic framework nanocarrier for NIR imaging-guided photothermal therapy

Yawei Li, Na Xu, Junli Zhou et al. · Biomaterials Science · 2018 · 56 citations

Pharmacy, Materials Science, Pharmaceutics +17

ABT737 induces mitochondrial pathway apoptosis and mitophagy by regulating DRP1-dependent mitochondrial fission in human ovarian cancer cells

Yang Yu, Lu Xu, Qi Ling et al. · Biomedicine & Pharmacotherapy · 2017 · 47 citations

Life Sciences, Cell Biology, Oncology +16